During the past decade, L V Prasad Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "L V Prasad Eye Institute" are "Macular Edema" (1 trials), "Non Arteritic Anterior Ischemic Optic Neuropathy" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "L V Prasad Eye Institute" in a lesser frequency.

Most popular intervention types in "L V Prasad Eye Institute" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lucentis or Avastin" (1 trials), "QPI-1007 Injection - 1.5 mg" (1 trials), "QPI-1007 Injection - 3.0 mg" (1 trials), "Sham Injection Procedure" (1 trials) and "suprachoroidal CLS-TA" (1 trials). Other intervention names were less common.

The vast majority of trials in "L V Prasad Eye Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "L V Prasad Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in L V Prasad Eye Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in L V Prasad Eye Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".